Acurx pharmaceuticals, inc. to discuss 2022 third quarter financial results on november 14, 2022 conference call and provide business update

Staten island, n.y. , nov. 1, 2022 /prnewswire/ -- acurx pharmaceuticals, inc. (nasdaq: acxp) ("acurx" or the "company"), a clinical stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, announced today that the company will release its 2022 third quarter financial results on monday, november 14, 2022, at 8:30 am et before the u.s. financial markets open.
ACXP Ratings Summary
ACXP Quant Ranking